A unique cytotoxic CD4(+) T cell‐signature defines critical COVID‐19

OBJECTIVES: SARS‐CoV‐2 infection causes a spectrum of clinical disease presentation, ranging from asymptomatic to fatal. While neutralising antibody (NAb) responses correlate with protection against symptomatic and severe infection, the contribution of the T‐cell response to disease resolution or pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Baird, Sarah, Ashley, Caroline L, Marsh‐Wakefield, Felix, Alca, Sibel, Ashhurst, Thomas M, Ferguson, Angela L, Lukeman, Hannah, Counoupas, Claudio, Post, Jeffrey J, Konecny, Pamela, Bartlett, Adam, Martinello, Marianne, Bull, Rowena A, Lloyd, Andrew, Grey, Alice, Hutchings, Owen, Palendira, Umaimainthan, Britton, Warwick J, Steain, Megan, Triccas, James A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461786/
https://www.ncbi.nlm.nih.gov/pubmed/37645435
http://dx.doi.org/10.1002/cti2.1463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461786/
https://www.ncbi.nlm.nih.gov/pubmed/37645435
http://dx.doi.org/10.1002/cti2.1463

Ejemplares similares